These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12075855)

  • 1. Protection of dopaminergic neurons in primary culture by lisuride.
    Gille G; Rausch WD; Hung ST; Moldzio R; Ngyuen A; Janetzky B; Engfer A; Reichmann H
    J Neural Transm (Vienna); 2002 Feb; 109(2):157-69. PubMed ID: 12075855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture.
    Moldzio R; Radad K; Duvigneau JC; Kranner B; Krewenka C; Piskernik C; Rausch WD
    J Neural Transm (Vienna); 2006 Sep; 113(9):1095-105. PubMed ID: 16463121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pergolide protects dopaminergic neurons in primary culture under stress conditions.
    Gille G; Rausch WD; Hung ST; Moldzio R; Janetzky B; Hundemer HP; Kolter T; Reichmann H
    J Neural Transm (Vienna); 2002 May; 109(5-6):633-43. PubMed ID: 12111455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
    Takashima H; Tsujihata M; Kishikawa M; Freed WJ
    Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyl-L-methionyl-L-Dopa-methyl ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity.
    Minelli A; Conte C; Prudenzi E; Cacciatore I; Cornacchia C; Taha E; Pinnen F
    Free Radic Biol Med; 2010 Jul; 49(1):31-9. PubMed ID: 20307650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
    Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
    J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production.
    Xie J; Duan L; Qian X; Huang X; Ding J; Hu G
    J Neurosci Res; 2010 Feb; 88(2):428-37. PubMed ID: 19746425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.
    Storch A; Burkhardt K; Ludolph AC; Schwarz J
    J Neurochem; 2000 Dec; 75(6):2259-69. PubMed ID: 11080177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.
    Gille G; Radad K; Reichmann H; Rausch WD
    J Neural Transm (Vienna); 2006 Sep; 113(9):1107-18. PubMed ID: 16252065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture.
    Callier S; Le Saux M; Lhiaubet AM; Di Paolo T; Rostène W; Pelaprat D
    J Neurochem; 2002 Jan; 80(2):307-16. PubMed ID: 11902121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models.
    Jeon MY; Lee WY; Kang HY; Chung EJ
    Neurol Res; 2007 Apr; 29(3):289-95. PubMed ID: 17509229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
    Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
    Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress.
    Mytilineou C; Walker RH; JnoBaptiste R; Olanow CW
    J Pharmacol Exp Ther; 2003 Feb; 304(2):792-800. PubMed ID: 12538835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degeneration.
    Hartikka J; Staufenbiel M; Lübbert H
    J Neurosci Res; 1992 Jun; 32(2):190-201. PubMed ID: 1357186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro.
    Nakao N; Nakai K; Itakura T
    Brain Res; 1997 Nov; 777(1-2):202-9. PubMed ID: 9449429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine.
    Shinpo K; Kikuchi S; Sasaki H; Moriwaka F; Tashiro K
    J Neurosci Res; 2000 Nov; 62(3):374-82. PubMed ID: 11054806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.